Trial intelligence / Profile preview

Simethicone with 2L PEG for Colonoscopy Bowel Cleansing

NCT02540239Completed

Sponsor
Changhai Hospital
Start
Jan 2015
Primary completion
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of simethicone in colorectal cancer (CRC) and colonic polyps (2 arms), sponsored by Changhai Hospital. Primary endpoints: Adenoma Detection Rate at 2 days, Boston Bowel Preparation Scale at 2 days and 1 more. Started Jan 2015; status: completed.

02

Drugs

simethicone
03

Conditions

colorectal cancer (CRC)colonic polyps

Beyond the preview

Go deeper on NCT02540239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02540239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call